CMMBVSNRSN• 3 Months (Normalized)
CMMB vs NRSN (Chemomab Therapeutics Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-26.43%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
NRSN Performance $4.78
+575.14%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-601.57 pts
NRSN outperforming by 601.57 percentage points
CMMBNRSN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | CMMB Price | CMMB Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -26.43% | $4.78 | +575.14% | -601.57% |
| Sep 28, 2026 | $1.64 | -27.75% | $5.10 | +620.34% | -648.09% |
| Sep 25, 2026 | $2.16 | -4.85% | $6.95 | +881.64% | -886.49% |
| Sep 24, 2026 | $2.20 | -3.08% | $7.40 | +945.20% | -948.28% |
| Sep 23, 2026 | $2.28 | +0.44% | $7.40 | +945.20% | -944.76% |
| Sep 22, 2026 | $2.51 | +10.57% | $7.18 | +914.12% | -903.55% |
| Sep 21, 2026 | $2.48 | +9.25% | $6.62 | +835.03% | -825.78% |
| Sep 18, 2026 | $2.61 | +14.98% | $6.35 | +796.89% | -781.91% |
| Sep 17, 2026 | $2.80 | +23.35% | $6.72 | +849.15% | -825.80% |
| Sep 16, 2026 | $2.65 | +16.74% | $6.49 | +816.67% | -799.93% |
| Sep 15, 2026 | $2.47 | +8.81% | $7.03 | +892.94% | -884.13% |
| Sep 14, 2026 | $2.45 | +7.93% | $6.90 | +874.58% | -866.65% |
| Sep 11, 2026 | $2.58 | +13.66% | $0.35 | -50.99% | +64.65% |
| Sep 10, 2026 | $2.60 | +14.54% | $0.33 | -53.11% | +67.65% |
| Sep 09, 2026 | $2.69 | +18.50% | $0.40 | -43.36% | +61.86% |
Page 1 of 5